ARCHIVES

UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says

This article is from The Cancer Letter archive.

Vol. 25 No. 36 | September 24, 1999

Download PDF Visit The Full Archive

Related Articles

NCI Programs: BSA Approves Formation Of Two Grant Programs:

July 2, 1999

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

February 25, 2011

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013

St. Jude Begins $100 Million Expansion Program

December 4, 1987

NCI Preliminary Budge For 1979 By Mechanism

June 3, 1977

Advisers Fume Over Preventions Budget Cut; NIH Probably Did It

May 22, 1992